Insights
How's it going for pharma SMEs in the EU?
04 Sept 2024In the EU, there are regulations - lots of them. There's even a specific regulation for micro, small and medium-sized enterprises (SMEs) in the pharma sector. The EU is seeking opinions on support for pharmaceutical SMEs.
Did adjective apply to the whole list or just the first item? Court of Appeal gives ruling
25 Sept 2024Sometimes, parties to contracts look back at the wording they used and wish they would have been clearer.
Five Top Tips for CPSEs
22 Oct 2024What is the nature and purpose of CPSEs and how can you approach completing them?
Poorly drafted no assignment clause did not stop novation by conduct
18 Oct 2024A contractual clause prohibiting assignment without the other party's prior written consent did not stop the novation (ie replacement) of one of the parties by another party, the High Court has ruled.
Life Sciences and sustainability shine in new UK industrial strategy
19 Nov 2024"Growth is the number one mission of this government. Our new Industrial Strategy is central to that Growth Mission". So starts the Green Paper setting out the new UK Government's vision for an Industrial Strategy that plans to 2035 and beyond.
Protecting data: implications of the Cyber Security and Resilience Bill for the UK's pharmaceuticals and life sciences sector
19 Nov 2024The proposed Cyber Security and Resilience Bill (the Bill) intends to capture more sectors, increase incident reporting and strengthen ICO powers - we consider the potential implications for the UK's pharmaceuticals and Life Sciences sector.
